CDMO, CRO Services
Total Trials
4
As Lead Sponsor
0
As Collaborator
Total Enrollment
143
NCT04803708
Bacteriophage Therapy TP-102 in Diabetic Foot Ulcers
Phase: Phase 1/2
Role: Collaborator
Start: Mar 22, 2021
Completion: Sep 5, 2022
NCT05948592
Bacteriophage Therapy TP-102 in Patients With Diabetic Foot Infection
Phase: Phase 2
Start: Nov 8, 2023
Completion: Dec 31, 2025
NCT06370598
Phase 1/2a to Assess the Safety and Tolerability of TP-122A for the Treatment of Ventilator-Associated Pneumonia
Start: Sep 30, 2024
Completion: Jun 30, 2025
NCT06677229
Phase 1b/2a Clinical Trial to Determine the Safety, Tolerability and Efficacy of TZ-161 in Spinal Cord Injury
Start: Aug 1, 2025
Completion: Jun 30, 2027
Loading map...